Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 20 articles:
HTML format
Text format



Single Articles


    October 2018
  1. WALSH PC
    RE: Risk of Prostate Cancer in Men Treated With 5alpha-Reductase Inhibitors-A Large Population-Based Prospective Study.
    J Natl Cancer Inst. 2018 Oct 30. pii: 5149366. doi: 10.1093.
    PubMed     Text format    


  2. ZHAO SG, Lehrer J, Chang SL, Das R, et al
    The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target.
    J Natl Cancer Inst. 2018 Oct 13. pii: 5129111. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. MADAN RA, Gulley JL
    Finding an Immunologic Beachhead in the Prostate Cancer Microenvironment.
    J Natl Cancer Inst. 2018 Oct 13. pii: 5129110. doi: 10.1093.
    PubMed     Text format    


  4. YOO YA, Vatapalli R, Lysy B, Mok H, et al
    The Role of Castration-Resistant Bmi1+Sox2+ Cells in Driving Recurrence in Prostate Cancer.
    J Natl Cancer Inst. 2018 Oct 11. pii: 5127127. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. KARTHAUS WR, Sawyers CL
    Strategies to Identify and Target Cells of Origin in Prostate Cancer.
    J Natl Cancer Inst. 2018 Oct 11. pii: 5127123. doi: 10.1093.
    PubMed     Text format    


    September 2018
  6. MEIER KE
    Omega-3 Fatty Acids and Prostate Cancer: G Protein-Coupled Receptors to the Rescue.
    J Natl Cancer Inst. 2018 Sep 6. pii: 5091908. doi: 10.1093.
    PubMed     Text format    


  7. LIANG P, Henning SM, Guan J, Grogan T, et al
    Role of Host GPR120 in Mediating Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer.
    J Natl Cancer Inst. 2018 Sep 6. pii: 5091911. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  8. YARMOLINSKY J, Bonilla C, Haycock PC, Langdon RJQ, et al
    Circulating Selenium and Prostate Cancer Risk: A Mendelian Randomization Analysis.
    J Natl Cancer Inst. 2018 May 17. pii: 4996958. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  9. VERMA V, Simone CB 2nd, Mishra MV
    Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


    March 2018
  10. WALLERSTEDT A, Strom P, Gronberg H, Nordstrom T, et al
    Risk of Prostate Cancer in Men Treated With 5alpha-Reductase Inhibitors-A Large Population-Based Prospective Study.
    J Natl Cancer Inst. 2018 Mar 14. pii: 4935092. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. THOMPSON I JR., Goodman P, Tangen C
    Reduced Risk of Prostate Cancer With 5alpha-Reductase Inhibitors.
    J Natl Cancer Inst. 2018 Mar 14. pii: 4935098. doi: 10.1093.
    PubMed     Text format    


  12. UNGER JM, Hershman DL, Till C, Tangen CM, et al
    Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial.
    J Natl Cancer Inst. 2018 Mar 9. pii: 4925555. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  13. JOHNSON SB, Park HS, Gross CP, Yu JB, et al
    Use of Alternative Medicine for Cancer and Its Impact on Survival.
    J Natl Cancer Inst. 2018;110.
    PubMed     Text format     Abstract available


    December 2017
  14. WYATT AW, Annala M, Aggarwal R, Beja K, et al
    Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    October 2017
  15. BROUGHMAN JR, Basak R, Nielsen ME, Reeve BB, et al
    Prostate Cancer Patient Characteristics Associated With a Strong Preference to Preserve Sexual Function and Receipt of Active Surveillance.
    J Natl Cancer Inst. 2017 Oct 16. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2017
  16. CONTI DV, Wang K, Sheng X, Bensen JT, et al
    Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    April 2017
  17. BRIOLLAIS L, Ozcelik H, Xu J, Kwiatkowski M, et al
    Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    March 2017
  18. KELLY SP, Graubard BI, Andreotti G, Younes N, et al
    Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.
    J Natl Cancer Inst. 2017;109:1-9.
    PubMed     Text format     Abstract available


    February 2017
  19. POLLACK A, Kwon D, Walker G, Khor LY, et al
    Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer.
    J Natl Cancer Inst. 2017;109:1-8.
    PubMed     Text format     Abstract available


    January 2017
  20. GAO X, Li LY, Rassler J, Pang J, et al
    Prospective Study of CRMP4 Promoter Methylation in Prostate Biopsies as a Predictor For Lymph Node Metastases.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: